OBJECTIVE: Barbiturate coma therapy (BCT) has been known to be an useful method to control increased intracranial pressure (IICP) refractory to medical and surgical treatments. We have used BCT for patients with severe IICP during the past 10 years, and analyzed our results with review of literatures. METHODS: We analyzed 92 semicomatose or comatose patients with Glasgow coma scale (GCS) of 7 or less with severe IICP due to cerebral edema secondary to parenchymal damages irrespective of their causes. Forty patients who had received BCT with ICP monitoring from January 1997 to December 2006 were included in BCT group, and fifty-two patients who had been managed without BCT from January 1991 to December 1995 were divided into control group. We compared outcomes with Glasgow outcome scale (GOS) and survival rate between the two groups. RESULTS: Good outcome (GOS=4 and 5) rates at 3-month after insult were 27.5% and 5.8% in BCT and control group, respectively (p<0.01). One-year survival rates were 35.9% and 12.5% in BCT and control group, respectively (p<0.01). In BCT group, the mean age of good outcome patients (37.1 +/- 14.9) was significantly lower than that of poor outcome patients (48.1 +/- 13.5) (p<0.05). CONCLUSION: With our 10-year experience, we suggest that BCT is an effective treatment method for severe IICP patients for better survival and GOS, especially for younger patients.
OBJECTIVE:Barbituratecoma therapy (BCT) has been known to be an useful method to control increased intracranial pressure (IICP) refractory to medical and surgical treatments. We have used BCT for patients with severe IICP during the past 10 years, and analyzed our results with review of literatures. METHODS: We analyzed 92 semicomatose or comatosepatients with Glasgow coma scale (GCS) of 7 or less with severe IICP due to cerebral edema secondary to parenchymal damages irrespective of their causes. Forty patients who had received BCT with ICP monitoring from January 1997 to December 2006 were included in BCT group, and fifty-two patients who had been managed without BCT from January 1991 to December 1995 were divided into control group. We compared outcomes with Glasgow outcome scale (GOS) and survival rate between the two groups. RESULTS: Good outcome (GOS=4 and 5) rates at 3-month after insult were 27.5% and 5.8% in BCT and control group, respectively (p<0.01). One-year survival rates were 35.9% and 12.5% in BCT and control group, respectively (p<0.01). In BCT group, the mean age of good outcome patients (37.1 +/- 14.9) was significantly lower than that of poor outcome patients (48.1 +/- 13.5) (p<0.05). CONCLUSION: With our 10-year experience, we suggest that BCT is an effective treatment method for severe IICP patients for better survival and GOS, especially for younger patients.
Authors: N A Martin; R V Patwardhan; M J Alexander; C Z Africk; J H Lee; E Shalmon; D A Hovda; D P Becker Journal: J Neurosurg Date: 1997-07 Impact factor: 5.115
Authors: Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright Journal: J Neurotrauma Date: 2007 Impact factor: 5.269
Authors: D F Kelly; D B Goodale; J Williams; D L Herr; E T Chappell; M J Rosner; J Jacobson; M L Levy; M A Croce; A H Maniker; G J Fulda; J V Lovett; O Mohan; R K Narayan Journal: J Neurosurg Date: 1999-06 Impact factor: 5.115
Authors: Jeong-Am Ryu; Wonkyung Jung; Yoo Jin Jung; Do Yeon Kwon; Kina Kang; Hyeok Choi; Doo-Sik Kong; Ho Jun Seol; Jung-Il Lee Journal: PLoS One Date: 2019-04-17 Impact factor: 3.240
Authors: Arnošt Mládek; Václav Gerla; Petr Šeba; Vladimír Kolář; Petr Skalický; Helen Whitley; Lenka Lhotská; Vladimír Beneš; Ondřej Bradáč Journal: Sci Rep Date: 2021-07-12 Impact factor: 4.379